Stock Trading Canary

中文

← Hong Kong

HONG KONG · DIRECTORS' NOTICES

Abbisko Cayman Ltd. - B

02256 · Healthcare · Biotechnology

Score

Not ranked: no net buying on the exchange by a director in the last 180 days.

Price vs insider buying

2256.HK · HKD

● Purchase × Sale ◇ Public disclosure ▥ 15-day cluster ·

Circles and crosses mark trade dates; diamonds below the axis mark later public disclosures. The trade became public on its disclosure date. Prices are nearest-session closes, not insider execution prices. Marker sizes are not compared when values or currencies differ.

Director trades on the exchange

Purchases and sales on the exchange in the last 12 months, as counted in the score.

Trade dateFiledDirectorHeld asTradeSharesPriceValue
2026-04-082026-04-09YU HONGPING—Sold6,000HK$13.26HK$79.5K
2026-04-022026-04-09JI JING—Sold60,000HK$13.07HK$784.1K
2026-04-022026-04-09JI JING—Sold22,000HK$12.95HK$284.9K
2026-04-022026-04-09YU HONGPING—Sold25,000HK$13.18HK$329.6K
2026-04-012026-04-09YU HONGPING—Sold90,000HK$12.71HK$1.1M
2026-04-012026-04-09JI JING—Sold60,000HK$12.75HK$765.1K
Purchases not counted · 7

Director notices of a purchase that the score leaves out, and why.

Trade dateDirectorWhy not countedShares
2026-03-03Xu Yao-ChangHeld through a trust or jointly45,000
2025-06-12Xu Yao-ChangHeld through a trust or jointly17,000
2025-05-06Xu Yao-ChangHeld through a trust or jointly30,000
2025-03-13Xu Yao-ChangHeld through a trust or jointly40,000
2025-03-04Xu Yao-ChangHeld through a trust or jointly45,000
2024-04-02Xu Yao-ChangReplaced by an amendment115,000
2024-04-02Xu Yao-ChangReplaced by an amendment115,000